Cargando…
Evaluation of rosuvastatin-induced QT prolongation risk using real-world data, in vitro cardiomyocyte studies, and mortality assessment
Drug-induced QT prolongation is attributed to several mechanisms, including hERG channel blockage. However, the risks, mechanisms, and the effects of rosuvastatin-induced QT prolongation remain unclear. Therefore, this study assessed the risk of rosuvastatin-induced QT prolongation using (1) real-wo...
Autores principales: | Koo, Yeryung, Hyun, Sung-Ae, Choi, Byung Jin, Kim, Yujeong, Kim, Tae Young, Lim, Hong-Seok, Seo, Joung-Wook, Yoon, Dukyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199059/ https://www.ncbi.nlm.nih.gov/pubmed/37208484 http://dx.doi.org/10.1038/s41598-023-35146-z |
Ejemplares similares
-
Risk of QT prolongation through drug interactions between hydroxychloroquine and concomitant drugs prescribed in real world practice
por: Choi, Byung Jin, et al.
Publicado: (2021) -
Data-driven drug-induced QT prolongation surveillance using adverse reaction signals derived from 12-lead and continuous electrocardiogram data
por: Choi, Byung Jin, et al.
Publicado: (2022) -
Development of a Risk Score for QT Prolongation in the Intensive Care Unit Using Time-Series Electrocardiogram Data and Electronic Medical Records
por: Kim, Tae Young, et al.
Publicado: (2021) -
Risk Evaluation of Azithromycin-Induced QT Prolongation in Real-World Practice
por: Choi, Young, et al.
Publicado: (2018) -
Determinants of severe QT(c) prolongation in a real-world gerontopsychiatric setting
por: Schulze Westhoff, Martin, et al.
Publicado: (2023)